NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Musk vs. OpenAI: A Billion-Dollar Battle for Control of AI

A high-stakes trial is underway in Oakland, California, federal court, pitting Elon Musk, the billionaire entrepreneur, against OpenAI, the leading artificial intelligence firm. The trial centers on Musk's claim that OpenAI, led by Sam Altman, betrayed the company's original mission as a nonprofit to benefit humanity by forming a for-profit entity in March 2019, 13 months after Musk left the OpenAI board.

According to court documents, Musk is seeking $150 billion in damages from OpenAI and Microsoft, one of its largest investors, with proceeds going to OpenAI's charitable arm. Jury selection for the trial began on Monday, with Altman in attendance. The trial risks complicating OpenAI's plans for a potential initial public offering by casting doubt on its leadership.

The case is built on thousands of pages of internal documents revealed in court, including a diary entry from Greg Brockman, OpenAI's president and a co-founder. In the fall of 2017, Brockman wrote, "This is the only chance we have to get out from Elon. Is he the 'glorious leader' that I would pick?" The diary entry is part of the evidence that Musk's lawyers will use to argue that OpenAI's leaders were motivated by profit rather than the company's mission.

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

The trial also sheds light on how the CEOs with the most power to shape generative AI think about the technology. OpenAI has evolved from a nonprofit research lab in Brockman's apartment to a tech giant worth more than $850 billion. However, the company faces unprecedented competition from rivals including Anthropic, and is spending billions on computational resources.

CompanyValuation (2024)
OpenAI$850 billion
AnthropicUnknown
Microsoft$2.3 trillion

The trial comes at a sensitive time for both sides. OpenAI is preparing for a potential blockbuster IPO that could value the company at $1 trillion, while Musk's companies face similar pressures. His xAI, now folded into his rocket company SpaceX, trails far behind OpenAI in usage. SpaceX also plans to go public this year in what could be the biggest IPO ever.

According to court papers, Musk gave about $38 million of seed money to OpenAI between 2016 and 2020, mostly before he left the board. Musk's lawyers calculated damages by multiplying OpenAI's valuation and a portion of the nonprofit's stake that could be attributed to Musk's contributions. His team says between 50% and 75% of the nonprofit's stake can be attributed to Musk.

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

The trial is expected to feature testimony from heavy hitters in Silicon Valley, including Musk, Altman, and Microsoft CEO Satya Nadella. Shivon Zilis, a former OpenAI board member who is also mother to four of Musk's children, is likely to be a key witness. The truth and the law are on OpenAI's side, the company says, while Musk claims that the lawsuit is a baseless and jealous bid to derail a competitor.

Investor Takeaway

Investors should be cautious of potential governance issues at OpenAI, a leading AI firm.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.